在心肌病引起的心力衰竭和通过免疫吸附消除心脏自身抗体的自身免疫性
1German Centre for Heart and Circulatory Research (DZHK), Potsdamer Str. 58, 10785 Berlin, Germany.
Journal of clinical medicine
|February 13, 2025
概括
通过免疫吸收 (IA) 疗法消除β1-上腺受体自身抗体 (β1AR-AAbs) 改善了扩张性心肌病患者的结果. IA疗法在降低β1AR-AAbs和增强心脏功能方面显示出显著的益处,提供了一个有前途的治疗选择.
科学领域:
- 心脏病学 心脏病学
- 免疫学 免疫学 免疫学
- 内部医学 内部医学
背景情况:
- 自身免疫在心肌病症中发挥作用,β1-上腺受体自身抗体 (β1AR-AAbs) 参与疾病进展.
- 扩展性心肌病 (DCM) 与耐火性心力衰竭 (HF) 可能与升高的β1AR-AAbs.相关.
研究的目的:
- 审查自身免疫在心肌病病因病原发生的作用.
- 专注于针对β1AR-AAb阳性DCM患者的免疫吸附 (IA) 治疗,这些患者患有耐火性HF.
主要方法:
- 现有文献的叙述性审查.
- 对IA治疗在β1AR-AAb阳性DCM患者的疗效研究的分析.
主要成果:
- 高达97%的HF患者表现出增加的β1AR-AAbs,与HF严重程度相关.
- 在84-91%的患者中,IA治疗有效降低了β1AR-AAb水平.
- 大约80%的患者对IA有反应,显示左心室喷射率和心脏输出量有所改善.
结论:
- IA治疗耐受性很好,可以重复,即使在老年患者中.
- 心脏移植提供了显著的长期好处,包括改善心脏移植候选人的生存率.
- 对于适当选择的β1AR-AAb阳性DCM患者,IA治疗需要更多的考虑.
相关概念视频
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
374
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
374
Pathophysiology of Heart Failure
1.5K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
Myasthenia Gravis: Overview and Treatment
1.1K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.1K
Heart Failure Drugs: Inotropic Agents
504
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
504
Cell-mediated Immune Responses
66.7K
Overview
66.7K
Imbalances in Cardiac Output
1.3K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.3K


